Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms
- PMID: 12944191
- DOI: 10.1080/00365590310014760
Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms
Abstract
Objectives: To estimate the relationship between age and the values of different diagnostic tests in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic enlargement (BPE) and to compare prostate growth curves between the normal population sample, healthy men and men with LUTS.
Material and methods: A series of 354 men (mean age 70.2 years; range 45-91 years) with LUTS due to BPE were stratified into seven age groups and reviewed retrospectively. All patients underwent a standard evaluation, involving determination of the International Prostate Symptom Score (IPSS), digital rectal examination, uroflowmetry, determination of the prostate-specific antigen (PSA) level and transrectal ultrasonography. Descriptive statistics were used to describe all the variables and Spearman's correlation test was used to evaluate the relationships between them.
Results: The mean prostate volume was 40.1 (+/-23.9) cm(3) and mean PSA concentration 3.9 (+/-4.2) ng/ml. Both values increased progressively from 27.5 ml and 1.5 ng/ml, respectively in the <54 years age group to 48.2 ml and 5.4 ng/ml, respectively in the <80 years age group. However, in the 75-79 years age group there was a decrease in both prostate volume and symptom score; PSA concentration remained unchanged and maximal flow rate increased slightly. A statistically significant but weak correlation was found between prostate volume and age (r = 0.25, p < 0.0001) and between PSA and age (r = 0.28, p < 0.0001). Prostate volume correlated positively with serum PSA (r = 0.54, p < 0.0001). The correlations between maximum flow rate and age, prostate volume, PSA and IPSS were r = -0.21, p < 0.0001; r = -0.18, p < 0.0006; r = -0.29, p < 0.0001; and r = 0.14, p < 0.0098, respectively.
Conclusions: These data confirm that prostate volume and serum PSA concentration are significantly correlated and increase with advanced age. The correlations between uroflowmetry (Qmax) and age, prostate volume, serum PSA and IPSS were also significant. However, there was no relationship between symptoms and objective measures of BPE. The increase in different parameters of the severity of benign prostatic hyperplasia with advanced age is not continuous. The prostate volume alone is not useful in the estimation of disease severity.
Similar articles
-
Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology.Urology. 2000 Mar;55(3):397-402. doi: 10.1016/s0090-4295(99)00473-2. Urology. 2000. PMID: 10699620
-
Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older.World J Urol. 2011 Apr;29(2):171-8. doi: 10.1007/s00345-010-0638-z. Epub 2011 Jan 8. World J Urol. 2011. PMID: 21221974
-
[Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].Hell J Nucl Med. 2007 May-Aug;10(2):138-43. Hell J Nucl Med. 2007. PMID: 17684595 Greek, Modern.
-
EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.Eur Urol. 2015 Jun;67(6):1099-1109. doi: 10.1016/j.eururo.2014.12.038. Epub 2015 Jan 19. Eur Urol. 2015. PMID: 25613154 Review.
-
Comprehensive patient evaluation for benign prostatic hyperplasia.Urology. 1998 Apr;51(4A Suppl):13-8. doi: 10.1016/s0090-4295(98)00050-8. Urology. 1998. PMID: 9586591 Review.
Cited by
-
Lack of association between the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene polymorphism and the risk of benign prostatic hyperplasia in Caucasian men.Mol Biol Rep. 2013 Dec;40(12):6665-9. doi: 10.1007/s11033-013-2781-2. Epub 2013 Sep 21. Mol Biol Rep. 2013. PMID: 24057187
-
Is There a Correlation Between Behçet Disease and Lower Urinary Tract Symptoms?Int Neurourol J. 2020 Jun;24(2):150-155. doi: 10.5213/inj.2040004.002. Epub 2020 Jun 30. Int Neurourol J. 2020. PMID: 32615677 Free PMC article.
-
Effect of 5-alpha Reductase Inhibitor on Storage Symptoms in Patients with Benign Prostatic Hyperplasia.Int Neurourol J. 2011 Sep;15(3):152-7. doi: 10.5213/inj.2011.15.3.152. Epub 2011 Sep 30. Int Neurourol J. 2011. PMID: 22087424 Free PMC article.
-
Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer.Prostate Cancer Prostatic Dis. 2023 Dec;26(4):787-794. doi: 10.1038/s41391-022-00627-1. Epub 2022 Dec 8. Prostate Cancer Prostatic Dis. 2023. PMID: 36482081 Free PMC article.
-
Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia.Prostate Int. 2016 Jun;4(2):43-8. doi: 10.1016/j.prnil.2016.03.002. Epub 2016 Mar 11. Prostate Int. 2016. PMID: 27358842 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous